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Abstract
 Bacterial pathogens can manipulate or subvert host tissue cellsBackground:
to their advantage at different stages during infection, from initial colonization in
primary host niches to dissemination. Recently, we have shown that 
 (ML), the causative agent of human leprosy,Mycobacterium leprae
reprogrammed its preferred host niche de-differentiated adult Schwann cells to
progenitor/stem cell-like cells (pSLC) which appear to facilitate bacterial
spread. Here, we studied how this cell fate change influences bacterial
retention and transfer properties of Schwann cells before and after
reprogramming.
 Using primary fibroblasts as bacterial recipient cells, we showed thatResults:
non-reprogrammed Schwann cells, which preserve all Schwann cell lineage
and differentiation markers, possess high bacterial retention capacity when
co-cultured with skin fibroblasts; Schwann cells failed to transfer bacteria to
fibroblasts at higher numbers even after co-culture for 5 days. In contrast,
pSLCs, which are derived from the same Schwann cells but have lost Schwann
cell lineage markers due to reprogramming, efficiently transferred bacteria to
fibroblasts within 24 hours.
 ML-induced reprogramming converts lineage-committedConclusions:
Schwann cells with high bacterial retention capacity to a cell type with pSLC
stage with effective bacterial transfer properties. We propose that such
changes in cellular properties may be associated with the initial intracellular
colonization, which requires long-term bacterial retention within Schwann cells,
in order to spread the infection to other tissues, which entails efficient bacterial
transfer capacity to cells like fibroblasts which are abundant in many tissues,
thereby potentially maximizing bacterial dissemination. These data also
suggest how pathogens could take advantage of multiple facets of host cell
reprogramming according to their needs during infection.
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Introduction
The peripheral nervous system (PNS) is the preferred residence for one 
of the oldest bacterial pathogens known to mankind, Mycobacterium 
leprae (ML). It causes human leprosy, which is a chronic neurologi-
cal disease and still remains a public health problem1. The large gaps 
in our understanding of the infectious process have halted the pro-
gress towards developing effective early diagnostics and therapeutics 
for the management of nerve damage, the pathological hallmark of 
the disease. The distinctive peripheral nerve involvement is directly 
associated with the remarkable capacity of ML to invade the support-
ing glial cells of the adult PNS, Schwann cells2. Because peripheral 
nerves are a privileged site and are therefore protected from immune 
cells due to blood nerve barrier, Schwann cells provide a safer niche 
for ML survival, propagation and initial colonization.
One of the primary functions of Schwann cells is to synthesize the 
myelin sheath around axons that deliver rapid nerve conduction3. 
Despite the terminal differentiation of Schwann cells to a highly 
sophisticated myelinated phenotype, these mature Schwann cells 
show unprecedented plasticity; they can switch off their myelin 
program in response to injury and acquire a de-differentiated state 
resembling an immature phenotype, but maintain Schwann cell 
lineage properties4,5. ML appear to take advantage of this natural 
property and induce myelin damage (demyelination) as an adaptive 
mechanism to generate similar de-differentiated Schwann cells that 
are more favourable for bacterial colonization and manipulation6. 
We have recently shown that once infected these de-differentiated 
Schwann cells purified from adult nerves, they undergo a repro-
gramming process and convert to highly immature progenitor/stem 
cell-like cells (pSLC) that are more suitable for spreading infection 
to other tissues either by direct re-differentiation or through mac-
rophages7. However, it is not clear if fibroblasts, which are ubiqui-
tous in many tissues, could play an intermediary role by receiving 
ML and if so how pSLC differ from non-reprogrammed Schwann 
cells in terms of bacterial transfer.
In this study, using primary mouse fibroblasts as a model, we as-
sessed the bacterial transfer capacity of Schwann cells before and 
after reprogramming. We showed that before reprogramming, lin-
eage committed Schwann cells possess a high bacterial retention 
capacity. However, after reprogramming, which downregulated all 
Schwann cell lineage markers and myelin markers, Schwann cells 
lose bacterial retention and acquire an efficient bacterial transfer 
property to co-cultured fibroblasts. These findings show an exam-
ple of how a bacterial pathogen could use an induced cell fate 
change to suit its own ends during different stages of infectious 
process.
Materials and methods
Preparation of primary Schwann cells from adult peripheral 
nerves
Adult CD-1 mice (4–6 week old, ICR strain code: 022) and 6–8 week 
old GFP mice that constitutively express eGFP (strain: C57BL/6-Tg 
[ACTB-EGFP]1Osb/J, stock: 003291) were purchased from Charles 
River and Jackson Laboratories (Bar Harbor, ME). Animals were 
maintained at the Rockefeller University animal facilities in pathogen 
free cages. Institutional Animal Care and Use Committee (IACUC) at 
the Rockefeller University approved all animal procedures and ethi-
cal issues. For isolating Schwann cells, 6–8 mice were used and cells 
were then purified using magnetic cell sorting system and FACS sort-
ing using anti-p75 antibody (AB1554, Millipore, USA) as described7.
ML infection and reprogramming of mouse Schwann cells
Purified Schwann cells were grown in collagen coated T25 or T75 
flasks (BD Biosciences, NJ, USA) and infected with ML and repro-
grammed cells were generated according to our previous protocol7. 
In vivo-grown viable ML derived from nude-mouse footpads were 
prepared as described previously8. Briefly, p75+/Sox10+/Sox2+ 
Schwann cells purified from adult GFP-mice and wild type were 
infected with ML and maintained in Schwann cell media as 
described in details7. At day 3 post-infection, Schwann cells main-
tain p75+/Sox10+/Sox2+ and all other Schwann cell phenotype, 
and these infected cells were used in this study. In parallel, infect-
ed cells were incubated for four weeks and then FACS sorted for 
p75-cells; their phenotypes were confirmed as p75-/Sox10-/Sox2+, 
and reprogrammed cells were isolated from this population based 
on their ability to grow in mesenchymal stem cell media (StemCell 
Inc, Vancouver, Canada) and were termed as progenitor/stem-like 
cells (pSLC)7. pSLC were transduced with CopGFP-CDH-MSCV-
cG reporter vector9 obtained from System Biosciences (CA) and 
stable expression of copGFP in pSLC was performed as reported 
earlier7. GFP+pSLC were re-infected with ML in order to maintain 
similar bacterial load as with Schwann cells at day 3 post-infection, 
since reprogramming process that accompanies long incubation 
and cell proliferation causes bacterial dilution.
Preparation of primary neural and skin fibroblasts
Neural fibroblasts were prepared from adult CD-1 male mice 
(4–6 week old, ICR strain code: 022) at the same time when Schwann 
cells were prepared from these mice1. In brief, peripheral nerve tis-
sues were isolated in MEM (Invitrogen) and then digested with 
0.125% trypsin (Invitrogen)/0.05% EDTA and 0.1 mg/ml collagenase 
I (Worthington Biochemical) and passed through 100 micron mesh 
nylon filter (BD Falcon). Cells were collected and seeded on T25 
flask cultured in 10% FCS medium. Propagated cells negative for 
p75NGFR Schwann cell surface marker were separated by mag-
netic cell sorting system followed by FACS sorting using anti-p75 
antibody (AB1554, Millipore, USA). The purified p75-negative 
cells, which were also negative for Sox2 and Sox10 were used 
for co-culture experiments. Skin fibroblasts were prepared from 
adult wild-type mouse skin using a similar protocol described in 
detail previously10.
Bacterial retention and transfer determination and microscopy
Figure 1 summarizes the experimental scheme described below. 
Day 3-infected GFP+Schwann cells and re-infected GFP+pSLC 
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that carry >50–100 ML per cell (infection efficiency is >90%) were 
first washed to remove any extracellular ML and then co-cultured with 
GFP-negative fibroblasts for 18 hours, 3 and 7 days. Pre-evaluated 
culture medium containing DMEM with 6% serum (HyClone, USA) 
that suits short-term co-cultures, Schwann cell-fibroblasts and 
pSLC-fibroblasts co-culture combinations were selected. Although 
we used this medium for short-term cultures for quantification, both 
mesenchymal media without supplements and Schwann cell media 
were also supported cell growth for a short period with no apparent 
phenotypic change in Schwann cells and pSLC. 
Also, a possible release of bacteria to the culture media from infect-
ed pSLC was determined by using pooled culture media from day 2- 
cultured pSLC. Cell supernatants from infected pSLC were cen-
trifuged at 15,000 rpm for 20 minutes, and pelleted ML were re- 
suspended in 50 µl PBS, placed on glass coverslips and fixed and 
immunolabelled with anti-PGL-1 antibody as described below. As a 
positive control for ML, a suspension of ML in DMEM (1×106 ML/ml) 
was used. Whereas ML suspension showed numerous PGL-1+ ML, 
hardly any bacteria were detected from supernatants from pSLC. 
Bacterial transfer to non-GFP fibroblasts from GFP+ cells or bac-
terial retention within GFP+ cells were evaluated by immunolabe-
ling of fixed cultures using ant-PGL-1 antibody7 against GFP+/- 
detection. PGL-1/ML+ cells, both GFP+ and non-GFP cells, 
containing >50 ML per cells were quantified 18 hours, 3 and 5 
days after addition of fibroblasts. Data were analyzed for statistical 
significance using Student’s t test or by regression analysis (Sigma-
Plot). Paired sample analysis with P values <0.01 were considered 
as significant.
Immunofluorescence was performed as described7. In brief, cells 
were fixed with 4% formaldehyde (Sigma) for 10 min at room 
temperature and 100% methanol (Sigma) for 10 minutes at -20°C. 
The samples were washed with PBS, blocked with 10% goat serum 
and then incubated with primary antibody followed by second-
ary antibody conjugated with Alexa Fluor 488 or 594 (Invitrogen) 
as described; details of anti-p75 and anti-PGL-1 and secondary 
antibodies have been described previously7,14. Assays for apoptotic 
cells in co-cultures were performed using TUNEL assay kit (R&D 
Systems) according to manufactures instructions as described 
previously7,15. Images were captured with Nikon Eclipse 2100 
microscopy.
Gene-Expression analyses
Gene-Expression Analyses were performed using Affymetrix mouse 
gene chips according to Affymetrix protocol as described previ-
ously7. In brief, total RNA was isolated from uninfected/control 
Schwann cells, 3 days post-infection and pSLC derived from day 
28-infected Schwann cells using RNeasy columns (QIAGEN). 
Figure 1. Schematic illustrating the summary of the experimental approach and the results. GFP+ non-reprogrammed and reprogrammed 
Schwann cells (pSLC) that are infected with ML (red bacteria in green cells) are co-cultured with exogenously added primary fibroblasts 
(yellow) derived from adult peripheral nerves or skin. Evaluation of bacterial transfer to recipient fibroblasts from GFP+ cells after 18h and 
72h revealed an effective bacterial retention in non-reprogrammed cells (top) and a significant ML transfer to fibroblasts from reprogrammed 
Schwann cells (bottom).
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GFP mice show high susceptibility to ML infection. When GFP+ 
Schwann cells at day 3 post-infection were co-cultured with non-
GFP fibroblasts we found intracellular ML to be retained within the 
cytoplasm of Schwann cells after 3 and 5 days (Figure 3A). Bacterial 
transfer to GFP negative fibroblasts was minimal even after 5 days 
of co-culture. Identical results were obtained regardless of the tis-
sue type (neural or skin) from which fibroblasts were isolated and 
the media used for co-culturing the cells. These data suggest that 
non-reprogrammed Schwann cells, which preserve Schwann cell 
identity, expressing the full spectrum of Schwann cell lineage func-
tional markers (Figure 2C), retain ML in large numbers.
Reprogramming converts Schwann cells to a stem-like cell 
type with effective bacterial transfer capacity
When infected GFP+pSLC were co-cultured with primary mouse 
fibroblasts we found that most of the ML present within pSLC were 
transferred to non-GFP fibroblasts within 24 hours. Figure 3B shows 
the transfer of PGL-1+ ML to non-GFP fibroblasts when they co-
cultured for 18 hours or 3 days. Figure 1 illustrates the experimental 
scheme and summary of the results described below. Regardless of 
the origin of fibroblasts, whether they are neural fibroblasts (isolated 
from peripheral nerves) or dermal fibroblasts (isolated from adult 
skin), and regardless of choice of media for co-culture, mesenchymal 
media, DMEM with 6% serum or Schwann cell media, bacterial trans-
fer assays from pSLC showed similar results. Unlike macrophages, 
fibroblasts are not professional phagocytic cells equipped with highly 
potent immune mediators capable of killing bacteria and their host 
cells, and thus bacterial residence in fibroblasts may provide an 
immune-evasion strategy for ML with a decayed genome13. As ex-
pected, we could not detect any apoptotic GFP+pSLC debris phago-
cytosed by these fibroblasts in co-cultures. Therefore, ML transfer to 
fibroblasts from pSLC is unlikely to occur by an apoptosis-mediated 
mechanism, but mainly by a cell-to-cell transfer mechanism.
Discussion
Results presented in this study show an example of how a bacte-
rial pathogen could use cell fate change of its preferred host cellular 
niche to its own advantage during different stages of the infectious 
process, from bacterial colonization to bacterial transfer to fibro-
blasts that could facilitate the complex process of dissemination of 
infection. We have frequently observed that primary Schwann cells 
as mono-cultures retained intracellular ML for a long period with-
in Schwann cells, regardless of their species origin, rat, human or 
mouse1,14,15. Intriguingly, intracellular ML maintained Schwann cells 
without causing any apoptosis; this anti-apoptotic property is a de-
fining feature of ML as compared to other pathogenic bacteria15,16. 
Co-culture of infected GFP+ Schwann cells with high bacterial load 
with fibroblasts failed to produce a significant bacterial transmis-
sion even after 5 days (Figure 3). Such bacterial retention capacity 
in adult Schwann cells may also be of functional significance during 
human infection, since Schwann cells in leprosy patients are known 
to harbour ML for an extensive period, which may be critical for 
bacterial expansion within this privileged niche3,17. For this purpose, 
initial bacterial retention within Schwann cells is critical so that ML 
replication and colonization can be ensured. On the other hand, fol-
lowing sufficient intracellular propagation of ML within Schwann 
cells, the next step of the infectious process, as in many bacterial 
infections, is to transfer their progeny to a secure host cell type, 
Affymetrix Test3 arrays and mouse genome MG-430A2 arrays were 
probed with the cRNA prepared by reverse-transcription of the total 
RNA. Microarray data were processed by the Robust Multichip 
Average (RMA) method11. The R statistical programming language 
was used (version 2.15.2), in tandem with the Bioconductor Analysis 
suite (version 2.12)12. The resulting probe mRNA detection data 
was searched and selected for markers relating to Schwann cell 
lineage/myelination, based on published literature3–7. This list of 
probes contained duplicate probes for the same gene symbol and 
so was trimmed to include only one representative probe per gene 
symbol, both for clarity and due to space constraints. The data 
were presented in the form of heatmap representing expression of 
the genes (absolute log2 expression values) associated with these 
probes in each replicate at each time point. Genes were clustered 
by Euclidean distance and average linkage. Individual values and 
probes are shown in Supplemental table 1. Also, differentially 
expressed lineage marker genes (from means of replicates) were 
calculated as relative to control/uninfected cells in both day 
3-infected cells and pSLC state.
Results
Properties of infected non-reprogrammed and reprogrammed 
Schwann cells
Schwann cells purified from mouse adult peripheral nerves main-
tained Schwann lineage and myelin markers and are highly sus-
ceptible to ML infection7. In this study, we used Schwann cells 
which were infected with ML for 3 days, and previously described 
pSLC7 which were derived from reprogrammed Schwann cells 
after day 28 infection. Both day 3-infected Schwann cells and 
pSLC showed high level of infection and strict confinement of 
ML to the cytoplasm (Figure 2A and B). We found no evidence 
for bacterial leakage into the surrounding media when either cell 
type is cultured on its own. Supernatants collected from these 
cells after infection showed no evidence of ML in the media (data 
not shown). We next determine if ML infection at day 3 changed 
Schwann cell lineage marker expression when compared with 
pSLC, which are known to be reprogrammed cells exhibiting 
the loss of Schwann cell lineage markers7. Comparative analy-
ses revealed that infected Schwann cells at day 3 express a simi-
lar profile of Schwann cell lineage/myelination-related genes as 
compared to uninfected controls (Figure 2C-a). In contrast, pSLC 
showed a striking downregulation of the same markers. Absolute 
expression profiles of Schwann cell lineage/myelination-related 
genes are shown in Figure 2C-a. Differential expression of day 3- 
infected and pSLC as compared to uninfected control cells further 
revealed that there is almost no change in Schwann cell identity in 
cells at day 3 post-infection as compared to the marked downregu-
lation of the same genes in pSLC (Figure 2C-b). Since pSLC, but 
not cells infected for 3 days, lost Schwann cell identity, we refer to 
pSLC and infected Schwann cells at day 3 as reprogrammed and 
non-reprogrammed Schwann cells respectively (Figure 1C a, b).
Non-reprogrammed Schwann cells possess high bacterial 
retention capacity in the presence of fibroblasts
The difference between non-reprogrammed and reprogrammed 
Schwann cells at the mRNA level correlated with their capacity to 
maintain or transfer ML when primary fibroblasts were introduced 
to these cell types (Figure 1). GFP+ Schwann cells purified from 
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Figure 2. Properties of ML infected non-reprogrammed and reprogrammed Schwann cells. (A) Purified adult de-differentiated Schwann 
cells infected with ML for 3 days and labelled with antibodies to p75NTR (red) and ML-specific PGL-1 (green), counterstained with DAPI 
for nuclei (blue). (B) GFP pSCL (green) derived from day 28 infected Schwann cells labeled with anti-PGL1 and counterstained with DAPI 
(blue). Asterisks denote the absence of ML outside infected cells; ML strictly retain within the cytoplasm and no evidence of bacterial leakage 
to the surrounding when maintain as monocultures. Magnification: (A-a, b, c to B-a, b, c) 20x. (C) (a) Expression levels of known Schwann cell 
lineage/myelination genes, inferred by mRNA detection by Affymetrix Mouse microarray, from 2 samples (S1 and S2) each from control/uninfected 
Schwann cells, infected Schwann cells for 3 days (non-reprogrammed cells preserving Schwann cell identity) and pSLC-derived cells from day 
28-infected Schwann cells (reprogrammed cells with loss of Schwann cell identity). Genes are clustered by Euclidean distance and average 
linkage for clarity. (b) Differential expression (log2 fold change) of known Schwann cell lineage markers, shown as relative to control for both 
day 3 infected cells (left) and 28-day-derived pSLC-state cells (right). The mean of both replicates for each of the three time points was used 
when calculating log2 fold change relative to control. Note that both absolute (a) and differentially expressed (b) patterns show a high degree 
of similarity between control/uninfected and day 3-infected cells, as compared to marked downregulation of Schwann lineage/in pSLC. 
Robust Multichip Average (RMA) values representing, on a logarithmic scale (base 2), the relative abundance of an mRNA transcript for a 
given gene, shown as a colour scale from highest (around 10) to lowest (around 4). Colour scale for heatmap ranges between minimum and 
maximum detection of selected genes, while full array’s range was 2.4 to 14.2.
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Figure 3. Reprogramming significantly reduces ML retention capacity of adult Schwann cells and elevates bacterial transfer property 
to fibroblasts. (A) De-differentiated Schwann cells purified from adult peripheral nerves from GFP mice were infected with ML for 3 days and 
incubated with fibroblasts (isolated from wild type/non-GFP peripheral nerves) for another 3 (top panel) and 5 (bottom panel) days. Fixed 
co-cultures were labelled with antibody to ML-specific PGL-1 (red) and nuclei were counter stained with DAPI (blue). White arrows show non-
GFP fibroblasts with very few ML transferred from GFP+ Schwann cells. Note that almost all GFP+ Schwann cells carry high number of ML 
(yellow arrows). Inset shows GFP+ Schwann cells with typical bipolar morphology with content of ML (same as in bottom panel). (B, C) GFP+ 
reprogrammed Schwann cells, pSLC effectively transfer ML to exogenously added fibroblasts. GFP-pSLC were co-cultured with fibroblasts 
and fixed after 18h (B) and 3 days (C) and labelled with anti-PGL1 antibody. In B (top) shows the phase-contrast image and in C (top) cells 
are counterstained with DAPI (blue). Note that numerous ML were transferred to fibroblasts within 18h; arrows in B, C show PGL-1+ ML in 
non-GFP fibroblasts. Yellow arrows mark the GFP+pSLC (B, C). Magnification: (A, B, C) 20x. (D) Representative high-resolution confocal 
image (top) showing PGL-1 antibody-reactive intact rod-shaped ML (green; arrows) within fibroblasts (nucleus is labelled by DAPI; blue), 
and electron micrograph illustrating whole ML with electron transparent outer lipids (red arrows) in the cytoplasm of fibroblasts (bottom). 
(E) Quantitative analysis of bacterial retention in GFP+ non-reprogrammed Schwann cells as compared to GFP+ reprogrammed Schwann 
cells/pSLC in the presence of fibroblasts. * < p 0.01.
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which could serve as either mediator cells or vehicle that can spread 
the infection locally or systemically18. Tissue fibroblasts could serve 
as non-immune mediator cell types for spreading the infection, as 
they are ubiquitously present in many tissues whereas macrophages, 
which come to action following inflammatory responses, are known 
to serve as a vehicle for bacterial dissemination both locally and 
systemically19.
Once colonized, reprogramming of infected Schwann cells may be 
necessary for the conversion of bacterial retention capacity of par-
ent Schwann cells to a bacterial transfer property of reprogrammed 
Schwann cells for effective dissemination. We have recently 
shown that pSLC, but not Schwann cells, effectively transfer ML 
to macrophages in vivo under inflammatory conditions7. In this 
study, we showed that non-immune tissue cells like fibroblasts, 
which are much safer for ML survival than macrophages and are 
widely distributed (in the absence of inflammation) in peripheral 
nerves and skin, two preferred tissue niches for ML20, are a likely 
target for mediating bacterial dissemination. Effective ML transfer 
to neural fibroblasts is of particular significance, since neural fibro-
blasts, which are present in the peripheral nerve microenvironment 
could serve as an immediate target for ML once they colonized 
Schwann cells and subsequently undergo reprogramming. Thus, 
the reprogramming of Schwann cells provide ML with ample ad-
vantages – first to colonize intact Schwann cells and then to gradu-
ally change the fate of Schwann cells to the pSLC stage, promoting 
transfer of bacteria to fibroblasts or perhaps to other surrounding 
tissue cell types. Such a strategy suggests the intriguing possibility 
of effective bacterial spread to a wide range of tissues via pSLC as 
the reprogrammed form of infected Schwann cells also acquired 
other essential features such as re-differentiation, and migratory 
and immunomodulatory properties that are highly advantageous 
for bacterial dissemination. Therefore, we propose that the effec-
tive ML transfer capacity of the reprogrammed form of Schwann 
cells to fibroblasts could be a functionally-important event during 
ML dissemination.
Ubiquitous distribution of fibroblasts in almost all body tissues 
types suggests that pathogens are most likely to take advantage of 
these cells in order to reach or exit from their specific tissue niches. 
Neural fibroblasts are abundant in peripheral nerve tissues and ML 
may also use these cells during the exit from Schwann cells after 
colonization or simply use as a safe reservoir for bacterial survival 
during human infection21,22. Present studies showed that primary 
neural fibroblasts derived from peripheral nerves could indeed 
serve as a susceptible recipient cell type for ML when these fibro-
blasts contact with infected reprogrammed Schwann cells (pSLC). 
The new data from our study can be extended to the conditions 
associated with neuropathogenesis in leprosy patients, as neural 
fibroblasts in leprosy patients are known to secrete and deposit 
extracellular matrix components, particularly collagen and causes 
fibrotic conditions, contributing to the irreversible nerve damage 
observed in leprosy21–23. Under such conditions, fibroblasts har-
bouring ML could serve as an additional niche for bacterial survival, 
persistence and spread. Indeed, in leprosy patients and nine-band-
ed armadillos infected with ML, neural fibroblasts carrying high 
number of ML has been clearly demonstrated mostly in perineurial 
compartment22–24. Such bacterial persistence within neural fibro-
blasts may further perpetuate the nerve injury process by increased 
fibrosis and inflammation. Further molecular studies on this new 
role of fibroblasts in ML infection will provide novel insights into 
neuropathgenesis of ML infection and perhaps developing new 
strategies for preventing fibroblast-mediated bacterial spread from 
neural compartment to non-neural tissues.
The underlying mechanisms of effective bacterial retention in non-
reprogrammed Schwann cells and rapid bacterial transfer capac-
ity of pSLC are currently unknown. Based on the transcriptomic 
evidence from gene expression data it is possible that preserved 
Schwann cell identity in non-reprogammed cells and loss of 
Schwann cell identity in reprogrammed cells are associated with 
these two distinct functional properties. It is also intriguing that 
both non-reprogrammed and reprogrammed Schwann cells retain 
bacteria in the cytoplasm in the absence of exogenously added 
cells (Figure 1A and B). However, rapid transfer of bacteria to ex-
ogenously added fibroblasts occurs only when pSLC interact with 
fibroblasts or macrophages7, suggesting that signals received from 
recipient cells or interacting cells following cell-to-cell interaction 
could trigger the signals necessary for bacterial transfer process. 
Since apoptotic events are minimal or not detected in these pSLC 
and fibroblast co-culture conditions, bacterial transfer from pSLC 
to fibroblasts is likely mediated by non-apoptotic and cell-to-cell 
transfer mechanisms. Although mechanisms involving such cell-
to-cell bacterial transfer process appear to be highly complex, 
identification of details allow for the development of strategies to 
ablate bacterial spread at the early stage of infection.
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Table S1. Microarray data for Figure 1C. Robust Multichip Average (RMA) values for selected Schwann cell lineage markers, representing 
absolute gene expression as calculated across 6 microarrays, from 2 samples (S1 and S2) each from control/uninfected Schwann cells, 
infected Schwann cells for 3 days (non-reprogrammed cells preserving Schwann cell identity) and pSLC-derived cells from day 28-infected 
Schwann cells7.
Gene and Probe ID “Control (1)” “Control (2)” “Day 3 (1)” “Day 3 (2)” “pSLC (1)” “pSLC (2)”
“Tgfb1 (1420653_at)” 8.875085087 8.750895157 8.240683025 8.151701667 7.441773105 7.59125912
“Erbb3 (1434606_at)” 10.37548022 10.32681125 10.3069489 10.18805898 3.557050331 4.095306358
“Sox10 (1424985_a_at)” 8.771069925 8.756508626 8.740748716 8.70056877 5.645300737 5.467906393
“Plp1 (1425468_at)” 10.49937908 10.52663114 10.21998482 10.33987413 5.077788336 4.995512713
“Ngfr (1454903_at)” 10.42934191 10.26776964 10.75528146 10.66659223 4.974116673 4.74094638
“Lgi4 (1434121_at)” 9.391434237 9.35234632 9.014339856 9.056992656 4.786829187 3.791313289
“Mal (1432558_a_at)” 8.920254485 8.986191443 8.414628435 8.297979346 6.728140535 6.916327294
“Mpz (1423253_at)” 8.256161295 8.381011338 7.845112469 7.694736612 4.295568611 4.391234401
“S100b (1434342_at)” 6.899266755 7.029193803 8.242286924 8.204423493 4.173923744 4.505750456
“Qk (1425597_a_at)” 9.012841737 9.022546403 8.359367418 8.287088133 6.721881849 6.317931293
“Arhgef10 (1452302_at)” 7.921453062 7.896197547 7.64605098 7.766296023 7.576333594 7.610272438
“L1cam (1450435_at)” 11.22766628 11.33330355 11.21190865 11.35254211 5.658247758 5.340342385
“Egr2 (1427683_at)” 8.522475217 8.506068104 8.57181597 8.524460792 4.891965037 5.151886088
“Mbp (1419646_a_at)” 7.517747967 7.436965949 7.489265636 7.554494302 4.718879815 5.300037843
“Gal3st1 (1454078_a_at)” 10.04534115 9.950345605 9.470080807 9.457810701 4.324986565 4.37275971
“Gdnf (1419080_at)” 9.972677432 9.918438134 9.802476063 9.741177444 8.832869717 8.826992706
Supplementary table
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The studies described herein by Masaki ., extend earlier  modeling of - Schwann cellet al in vitro M. leprae 
interactions by this group that may be at the crux of neurological changes and various pathogenic
elements in leprosy. Specifically, this work describes phenotypic and transcriptome changes associated
with SC reprogramming following long-term (ML) infection that are associated with retention, orM. leprae 
loss of retention, of ML in coculture with fibroblasts. The loss of retentive behavior is measured by the
accrual of ML in fibroblasts placed in coculture with ML-infected normal or reprogrammed SC’s.
 
These studies attempt to recapitulate events occurring  and must always be appreciated within thein vivo
view of what is observed in the disease both at the clinical and histopathological level. To that end it would
be helpful for the authors to:
Place the phenomenon of “fibroblast infection” within the context of what is seen in clinical disease
with a few pertinent references.
 
Broaden the Discussion section to include how the author’s hypothesis of early dissemination of
ML from infected pSLC (intraneural compartment) fits with histopathological observations in
lepromatous leprosy infections (man and armadillo) which demonstrate a much higher bacterial
burden in the extraneural compartment as compared to the intraneural compartment.
 
Finally, since fibroblasts can take up  in culture and infected fibroblasts have been demonstratedM. leprae
in tissues of infected individuals and animals, I’m wondering whether the investigators did studies with ML
and fibroblasts alone. Depending on the outcome of these studies, some light might be shed on whether
the transfer to fibroblasts is actually an active process (e.g., cell-to-cell contact required) or passive in
nature. If data of this nature is available, it would enhance the investigator’s assertion that the
reprogramming of SC’s and loss of bacterial retention is an acquired property that leads to efficient
bacterial transfer to fibroblasts. Please expand on your position in the discussion to clarify.
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard, however I have significant reservations, as outlined
above.
 No competing interests were disclosed.Competing Interests:
 Yoshiko Takahashi
Department of Zoology, Kyoto University, Kyoto, Japan
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This study is a follow up of their previous discovery published in . The authors have describedCell, 2013
differences between non-programmed and programmed Schwann cells in their ML-retaining properties.
Unveiling these differences is an important step toward understanding how ML disseminates in the body.
The experiments were nicely done and the conclusion the authors tried to draw is justified.
I have one comment that must not be a big burden for the authors. This study deals with several different
types of cells, donor primary fibroblasts, non-programmed Schwann cells, programmed Schwann cells,
recipient fibroblasts derived from multiple origins etc. In addition, Schwann cells (either non-programmed
or programmed) are considered either “recipient” or “donor” dependent on which way ML bacteria
translocate. So, the story is a bit confusing for readers. My strong suggestion is that the authors might be
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translocate. So, the story is a bit confusing for readers. My strong suggestion is that the authors might be
willing to put one more figure in which the experimental scheme is summarized in a simple diagram. In
this way, fewer readers would need to repeatedly read the same sentences before getting points of what
authors want to describe.
The authors have properly addressed the comments in the previous report, which has improved the
paper.
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard.
 No competing interests were disclosed.Competing Interests:
 Maximiliano Gutierrez
MRC National Institute for Medical Research, London, UK
Approved: 05 November 2013
  05 November 2013Referee Report:
 doi:10.5256/f1000research.2880.r2293
I thank the authors for addressing and clarifying my specific comments. I appreciate the details that are
now provided in the new version and I do not have further comments.
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard.
 No competing interests were disclosed.Competing Interests:
Referee Responses for Version 1
 Maximiliano Gutierrez
MRC National Institute for Medical Research, London, UK
Approved with reservations: 10 October 2013
  10 October 2013Referee Report:
 doi:10.5256/f1000research.2381.r1922
This paper reports an intriguing aspect of the complex pathogenesis of the obligatory intracellular bacteria
. The authors report that ML infecting Schwann cells are not able to disseminate toM. leprae (ML)
fibroblasts but the cells re-programmed by the bacteria in stem-cell like cells are efficiently transferred to
the same cells . These observations are very interesting and contribute to our understanding of thein vitro
phenomenon of mycobacterial cell-to-cell transfer.
 
There are only three technical points I think that authors could consider in this work, to unambiguously
claim that the putative cell-to-cell transfer mechanism is a non-apoptotic, non-lytic one:
The authors stated as data not shown that there is not evidence of bacteria in supernatants. It
Page 13 of 15
F1000Research 2013, 2:198 Last updated: 19 JUN 2014
F1000Research
1.  
2.  
3.  
1.  
2.  
3.  
The authors stated as data not shown that there is not evidence of bacteria in supernatants. It
would be important to show this information and indicate in the methods how it was performed.
The authors mentioned that they could not detect any apoptotic GFP+pSLC debris. It would be
necessary to show these experiments as well, to exclude e.g. efferocytosis. They should indicate
in the methods how apoptosis was detected (markers, staining etc…).
The bacterial transfer to fibroblasts is measured primarily by detection of one lipid, PGL-1. It is
known that lipids from  can be transferred from infected cells to “bystander” cells (M. tuberculosis
). I understand that the system with ML is much more complicated, but wouldBeatty WL et al. 2000
it be possible to confirm that the fluorescent signal represent ‘intact’ bacteria e.g by electron
microscopy?
 
A minor comment: the authors refer to “strict confinement of ML to the cytoplasm” (results) or “retain
bacteria in the cytoplasm” (discussion). Do they mean intracellular?
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard, however I have significant reservations, as outlined
above.
 No competing interests were disclosed.Competing Interests:
1 Comment
Author Response
, University of Edinburgh, UKAnura Rambukkana
Posted: 17 Oct 2013
We thank the reviewer for the constructive and valid comments. We note here that because of the
short nature of this article we did not describe all negative results and present additional data in the
original version. Here we address and clarify these issues:
 
Evidence for the absence of bacteria in the supernatant and how it was performed is
now elaborated in the methods section of the revised manuscript.
 
 As described in our previous reports ( ), (Masaki ., 2013et al Tapinos and Rambukkana,
) apoptosis was measured using TUNNEL assay. It is known that  infection2005 M. leprae
does not induce apoptosis ( ), and in the present study no increase in Lahiri ., 2010et al M.
 TUNNEL-positive cells were detected in infected co-cultures as compared toleprae
uninfected cells.
 
Phenolic glycolipid-1 (PGL-1), particularly its sugar moieties, is very unique to  andM. leprae
is present in high quantity in the  cell wall. The latter permits the detection of intact M. leprae
 using antibodies against PGL-1. We have used a well-characterized antibodyM. leprae
(IgG) against the native sugar/lipid moieties of PGL-1 that has been widely used for
detecting whole/intact  in infected cells and tissues ( ; M. leprae Ng ., 2010et al Masaki ,et al.
). PGL-1 antibody activity has also been shown to correlate with acid-fast labeling2013
(Fite’s staining) that specifically stains intact mycobacteria in infected tissues (Masaki ., et al
). Considering the specificity and the detection of rod-shaped bacteria in high numbers2013
in non-GFP fibroblasts co-cultured with pSLC, it was concluded that anti-PGL1 antibody
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in non-GFP fibroblasts co-cultured with pSLC, it was concluded that anti-PGL1 antibody
detect the intact , but not free lipids. Moreover, high load of  inM. leprae M. leprae
non-reprogrammed Schwann cells (Fig. 2A), reflects the potential high content of bacterial
lipids in the cytoplasm, but we failed to detect any significant PGL positivity in fibroblasts
co-cultured with non-reprogrammed Schwann cells (Fig. 2A). This further suggests a lack of
active (or significant) bacterial lipid transfer from one cell to another under these
experimental conditions.
Nevertheless, to further clarify this point the updated version includes a representative
high-resolution fluorescence image of intact rod-shaped bacteria in fibroblasts detected by
anti-PGL-1 antibody. In addition, we also include a representative electron micrograph
showing the presence of intact  in fibroblasts (Fig. 2B). It should be noted thatM. leprae
infected fibroblasts are distinguishable from pSLC under the electron microscopy, since
pSLC, but not fibroblasts, form cell aggregates/clusters (Fig. 1a).
 
Minor comment: here we emphasize that all  detection is strictly intracellular.M. leprae
 No competing interests were disclosed.Competing Interests:
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